Ivy Elite Capital (as IEC) is a venture capital firm investing in cross-border projects/enterprises in Life Science and Clean Tech Industries. IEC is committed to providing capital to late staged medical companies (M&A or Pre-IPO) and growth staged Clean Tech companies (Expansion Investment). IEC strives to become the companies’ trustable partners. Beyond capital, we provide full services of the post-investment management to our portfolio companies, including strategic planning for future expansion, distribution channel setup, as well as identification and mitigation of risks. IEC is designated partner with Chinese local governments and co-invests with leading Chinese PE / VC funds. IEC also play a key consulting role during the cross-border investment in North America and China by providing professional consulting services, global market strategies and customized value-added services.